Loading insider details...
Latest Form 4 (Oct 2, 2026): Grant/Award of 308 EWTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 308 | n/a |
| Jul 1, 2026 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 319 | n/a |
| Jun 16, 2026 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 16,377 | n/a |
| Apr 3, 2026 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 339 | n/a |
| Jan 5, 2026 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 473 | n/a |
| Nov 13, 2025 | Edgewise Therapeutics, Inc. (EWTX) | Purchase | 10,700 | $199.4K |
| Oct 2, 2025 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 728 | n/a |
| Jul 2, 2025 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 858 | n/a |
| Jun 18, 2025 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 30,000 | n/a |
| Apr 3, 2025 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 559 | n/a |